Plasma-type gelsolin is decreased in human blood and cerebrospinal fluid after subarachnoid hemorrhage.
about
Plasma-type gelsolin in subarachnoid hemorrhage: novel biomarker today, therapeutic target tomorrow?Plasma gelsolin levels and outcomes after aneurysmal subarachnoid hemorrhageApplication of proteomics to cerebrovascular disease.Differential regulation of matrix-metalloproteinases and their tissue inhibitors in patients with aneurysmal subarachnoid hemorrhage.Elevated peripheral neutrophils and matrix metalloproteinase 9 as biomarkers of functional outcome following subarachnoid hemorrhage.Gelsolin decreases actin toxicity and inflammation in murine multiple sclerosis.A Pathway Proteomic Profile of Ischemic Stroke Survivors Reveals Innate Immune Dysfunction in Association with Mild Symptoms of Depression - A Pilot Study.Neurovascular matrix metalloproteinases and the blood-brain barrier.Investigation of the actin scavenging system in pre-eclampsia.Monitoring biomarkers of cellular injury and death in acute brain injury.Soluble and catalytically active endothelin converting enzyme-1 is present in cerebrospinal fluid of subarachnoid hemorrhage patients.Mechanisms of Global Cerebral Edema Formation in Aneurysmal Subarachnoid Hemorrhage.Change in blood gelsolin concentration in response to physical exercise.Increase of Soluble RAGE in Cerebrospinal Fluid following Subarachnoid Haemorrhage.Minocycline protects against delayed cerebral ischemia after subarachnoid hemorrhage via matrix metalloproteinase-9 inhibition.Expression of Cytoplasmic Gelsolin in Rat Brain After Experimental Subarachnoid Hemorrhage.The value of decreased plasma gelsolin levels in patients with systemic lupus erythematosus and rheumatoid arthritis in diagnosis and disease activity evaluation.Plasma Gelsolin: Indicator of Inflammation and Its Potential as a Diagnostic Tool and Therapeutic Target
P2860
Q33752073-3FA25792-817B-4409-BCCD-327A4EB0D15EQ33753676-45E55930-6B8C-4B3D-9ED7-92E3A7F5D991Q34312457-2FC79BEF-E01D-4E64-A70D-89BC1A3850A7Q34652720-70CC69E6-32C9-4177-8408-510349EFE623Q35608589-ABDB4AC3-BE86-4C46-8F49-756DC8BC0E8DQ36129472-A41C56AD-E4E8-44D9-AFB0-1B782D063675Q37002007-D32C5CBA-CB49-46C2-8CDD-5FF0BC015668Q37270697-8DCA9FB8-6866-4FF8-97E9-5A15C40CF00EQ37489759-B35AC417-8002-4215-B8E2-E4798C7E51D5Q38248158-21A5B593-AB98-4A60-B1B9-F5E5B48E2A96Q38629166-1E60CE75-EB56-458E-9DF1-2153497C4063Q39044188-A6119EE9-EDE2-4B49-8E0B-D3CD4B01C5D7Q42003996-565BE513-B098-4B94-8FDD-B038C8CDA335Q42177725-5BF2D21A-04BF-454B-95D7-EA2A118AD184Q47134916-BC6D7E73-0876-4BAF-A793-8731E97738E3Q48295351-5E4E242A-B71C-4293-893E-6D1FFF87C501Q54766883-D6A6B3D9-B24C-4528-B9CA-C0D18BD298A4Q58702505-BAB2450A-3D44-4182-9425-76D46FFF2C0F
P2860
Plasma-type gelsolin is decreased in human blood and cerebrospinal fluid after subarachnoid hemorrhage.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Plasma-type gelsolin is decrea ...... after subarachnoid hemorrhage.
@ast
Plasma-type gelsolin is decrea ...... after subarachnoid hemorrhage.
@en
type
label
Plasma-type gelsolin is decrea ...... after subarachnoid hemorrhage.
@ast
Plasma-type gelsolin is decrea ...... after subarachnoid hemorrhage.
@en
prefLabel
Plasma-type gelsolin is decrea ...... after subarachnoid hemorrhage.
@ast
Plasma-type gelsolin is decrea ...... after subarachnoid hemorrhage.
@en
P2093
P2860
P1433
P1476
Plasma-type gelsolin is decrea ...... after subarachnoid hemorrhage.
@en
P2093
Dana Gallacci
David Bauer
MingMing Ning
Po-Shun Lee
Rachael G Konigsberg
Sherry H-Y Chou
Steven K Feske
Suzanne Simmons
P2860
P304
P356
10.1161/STROKEAHA.111.631135
P407
P577
2011-09-22T00:00:00Z